These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21570721)

  • 1. Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery.
    Veiseh O; Kievit FM; Mok H; Ayesh J; Clark C; Fang C; Leung M; Arami H; Park JO; Zhang M
    Biomaterials; 2011 Aug; 32(24):5717-25. PubMed ID: 21570721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo safety evaluation of polyarginine coated magnetic nanovectors.
    Veiseh O; Kievit FM; Liu V; Fang C; Stephen ZR; Ellenbogen RG; Zhang M
    Mol Pharm; 2013 Nov; 10(11):4099-106. PubMed ID: 24099143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery.
    Veiseh O; Kievit FM; Fang C; Mu N; Jana S; Leung MC; Mok H; Ellenbogen RG; Park JO; Zhang M
    Biomaterials; 2010 Nov; 31(31):8032-42. PubMed ID: 20673683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells.
    Mok H; Veiseh O; Fang C; Kievit FM; Wang FY; Park JO; Zhang M
    Mol Pharm; 2010 Dec; 7(6):1930-9. PubMed ID: 20722417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma.
    Kievit FM; Veiseh O; Fang C; Bhattarai N; Lee D; Ellenbogen RG; Zhang M
    ACS Nano; 2010 Aug; 4(8):4587-94. PubMed ID: 20731441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.
    Wang K; Kievit FM; Sham JG; Jeon M; Stephen ZR; Bakthavatsalam A; Park JO; Zhang M
    Small; 2016 Jan; 12(4):477-87. PubMed ID: 26641029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by a mTOR siRNA-loaded cyclodextrin nanovector.
    Liu X; Wang G; You Z; Qian P; Chen H; Dou Y; Wei Z; Chen Y; Mao C; Zhang J
    Biomaterials; 2014 May; 35(14):4401-16. PubMed ID: 24582377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis.
    Ben Djemaa S; David S; Hervé-Aubert K; Falanga A; Galdiero S; Allard-Vannier E; Chourpa I; Munnier E
    Eur J Pharm Biopharm; 2018 Oct; 131():99-108. PubMed ID: 30063968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: synthesis, stability, cytotoxicity and MR imaging.
    Schweiger C; Pietzonka C; Heverhagen J; Kissel T
    Int J Pharm; 2011 Apr; 408(1-2):130-7. PubMed ID: 21315813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
    Ji M; Li P; Sheng N; Liu L; Pan H; Wang C; Cai L; Ma Y
    ACS Appl Mater Interfaces; 2016 Apr; 8(15):9565-76. PubMed ID: 27007621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilayer dual-polymer-coated upconversion nanoparticles for multimodal imaging and serum-enhanced gene delivery.
    He L; Feng L; Cheng L; Liu Y; Li Z; Peng R; Li Y; Guo L; Liu Z
    ACS Appl Mater Interfaces; 2013 Oct; 5(20):10381-8. PubMed ID: 24070392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambidextrous magnetic nanovectors for synchronous gene transfection and labeling of human MSCs.
    Yang J; Lee ES; Noh MY; Koh SH; Lim EK; Yoo AR; Lee K; Suh JS; Kim SH; Haam S; Huh YM
    Biomaterials; 2011 Sep; 32(26):6174-82. PubMed ID: 21696819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEI-Coated Fe₃O₄ Nanoparticles Enable Efficient Delivery of Therapeutic siRNA Targeting REST into Glioblastoma Cells.
    Wang R; Degirmenci V; Xin H; Li Y; Wang L; Chen J; Hu X; Zhang D
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stealth magnetic nanocarriers of siRNA as platform for breast cancer theranostics.
    Bruniaux J; Djemaa SB; Hervé-Aubert K; Marchais H; Chourpa I; David S
    Int J Pharm; 2017 Nov; 532(2):660-668. PubMed ID: 28506802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo.
    Chen Y; Lian G; Liao C; Wang W; Zeng L; Qian C; Huang K; Shuai X
    J Gastroenterol; 2013 Jul; 48(7):809-21. PubMed ID: 23179610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene delivery in three-dimensional cell cultures by superparamagnetic nanoparticles.
    Zhang H; Lee MY; Hogg MG; Dordick JS; Sharfstein ST
    ACS Nano; 2010 Aug; 4(8):4733-43. PubMed ID: 20731451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
    Luo X; Peng X; Hou J; Wu S; Shen J; Wang L
    Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells.
    Veiseh O; Kievit FM; Gunn JW; Ratner BD; Zhang M
    Biomaterials; 2009 Feb; 30(4):649-57. PubMed ID: 18990439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.